Literature DB >> 15630699

Repeat needle biopsies combined with clinical observation are safe and accurate in the management of a solitary pulmonary nodule.

James A Welker1, Mohammed Alattar, Sandeep Gautam.   

Abstract

BACKGROUND: Sixty percent of removed solitary pulmonary nodules (SPNs) are benign. An approach that reduces the unnecessary excision of benign nodules is consistent with the oncologic objective of organ preservation.
METHODS: A prospective observational study was performed at a lung cancer referral center in which consecutive patients were evaluated who presented with SPNs measuring < 4 cm on computed tomography (CT) scans. Patients underwent transbronchial biopsy (TBB), percutaneous needle aspiration (PCNA), clinical observation, repeat CT scans, and repeat biopsies. Patients were observed clinically and underwent repeat biopsies in an effort to reduce unnecessary surgical intervention.
RESULTS: One hundred eighteen patients underwent 194 biopsy sessions, including 137 TBB sessions and 57 PCNA sessions. The mean follow-up was 4 years. The shortest follow-up of a benign lesion was 3 years. The incidence of malignancy was 61%. The positive predictive value, negative predictive value, sensitivity, specificity, and accuracy all were 100%. Five patients had a delayed change in diagnosis from benign to malignant. This delay in diagnosis neither resulted in a change in tumor stage nor had an impact on patient management or survival.
CONCLUSIONS: Repeat needle biopsies combined with clinical observation and repeat CT scans can classify an SPN as benign versus malignant with 100% accuracy (95% confidence interval, 96.1-100.0%). An SPN diagnostic approach that includes a TBB, then PCNA, clinical observation, repeat CT scans, and repeat biopsies for continued suspicion of malignancy appears to reduce the unnecessary surgical excision of benign nodules from the current rate of 60% to 5% of SPN resections without affecting the survival of patients who have malignant SPNs. (c) 2004 American Cancer Society

Entities:  

Mesh:

Year:  2005        PMID: 15630699     DOI: 10.1002/cncr.20814

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  TBNA with and without EBUS: a comparative efficacy study for the diagnosis and staging of lung cancer.

Authors:  Junhong Jiang; Robert Browning; Noah Lechtzin; Jianan Huang; Peter Terry; Ko Pen Wang
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

2.  Granulomatous inflammation and organizing pneumonia: Role of computed tomography-guided lung fine needle aspirations, touch preparations and core biopsies in the evaluation of common non-neoplastic diagnoses.

Authors:  Anjali Saqi; Shana M Coley; John P Crapanzano
Journal:  Cytojournal       Date:  2014-01-31       Impact factor: 2.091

Review 3.  Role of rebiopsy in relapsed non-small cell lung cancer for directing oncology treatments.

Authors:  Antti P Jekunen
Journal:  J Oncol       Date:  2015-01-29       Impact factor: 4.375

4.  Correlation Between Circulating Tumor DNA Levels and Response to Tyrosine Kinase Inhibitors (TKI) Treatment in Non-Small Cell Lung Cancer.

Authors:  Zhangjing Wei; Wenyue Wang; Zitan Shu; Xue Zhou; Yanfang Zhang
Journal:  Med Sci Monit       Date:  2017-07-25

5.  Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Authors:  Irawati Lemonnier; Cédric Baumann; Nicolas Jay; Kazem Alzahouri; Patrick Arveux; Damien Jolly; Catherine Lejeune; Michel Velten; Fabien Vitry; Marie-Christine Woronoff-Lemsi; Francis Guillemin
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.